FDA Approved: MEKTOVI — Original Application (Array BioPharma Inc.)

View source ↗

Summary

FDA approved MEKTOVI (binimetinib) via an original NDA for unresectable or metastatic NRAS-mutant melanoma, marking the initial approval of the drug from Array …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Nras-mutant Melanoma

Drugs mentioned

• MEKTOVI (BINIMETINIB)

Snippet

ORIG AP for MEKTOVI (BINIMETINIB)